About Joseph S. Friedberg
Pleural and Lung Cancer
Works for Specialty Center
Board Certified in Surgery
Board Certified in Thoracic and Cardiac Surgery
“We’re bringing all the modalities to bear in fighting this disease. We are slowly nudging mesothelioma towards being more of a chronic disease, not a lethal one…Most people think it’s untreatable…but we don’t believe that’s the case,” wrote Dr. Joseph Friedberg and colleagues in the wake of a surprising discovery, published in the June 2011 issue of Annals of Thoracic Surgery.
Focus on Mesothelioma
Friedberg, Division Head of Thoracic Surgery at the University of Maryland School of Medicine, found that patients who underwent lung-sparing surgery in combination with photodynamic therapy showed superior overall survival rates than comparable patients who opted for the more traditional treatment of having an entire lung removed.
He previously was the chief of thoracic surgery and co-director of the Penn Mesothelioma and Pleural Diseases Program at the University of Pennsylvania Medical Center.
In hopes of developing treatments for advanced cancers and malignant mesothelioma, Friedberg has spearheaded several investigational trials. Included in those studies is research on the potential of a lung cancer vaccine.
Friedberg began seeing patients at the Greenebaum Cancer Center in late 2014, joining a multidisciplinary team of specialists. Together they review each case to develop a treatment plan specific to each patient.
Dr. Friedberg Chief of Thoracic Surgery
“Our primary motivation in attempting the lung-sparing surgery was preservation of quality of life. We were completely caught off guard when the analysis revealed a significantly longer survival for the patients who retained both lungs.”
Talk to a Doctor About Your Diagnosis
We can help you or a loved one get in contact with Dr. Friedberg and find the treatment that's best for you.Get Started Today
Friedberg received his medical degree from Harvard Medical School and completed specialized training in thoracic surgery at Brigham and Women’s Hospital. He is board-certified in thoracic surgery and is considered an expert at video-thoracoscopic procedures for treatment of chest diseases. His research findings have been profiled in several professional journals, including Clinical Cancer Research and the Journal of Clinical Oncology.See More Top Mesothelioma Doctors
- Pleural Malignancies
- Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma
- Photodynamic therapy for MPM: The Future of Treatment?
Disclaimer: Dr. Joseph S. Friedberg has no professional affiliation with Asbestos.com.
Share this article
Last Modified February 26, 2019
5 Cited Article Sources
- Retrieved from: https://www.pennmedicine.org/providers
- Retrieved from: http://www.dlpfoundation.org/research.php
- Retrieved from: https://www.pennmedicine.org/
- Retrieved from: http://news.pennmedicine.org/inside/2011/05/targeting-mesothelioma.html
- Retrieved from: http://www.uphs.upenn.edu/news/News_Releases/2011/06/asbestos/